The “COV-Boost” study was cited by British officials when they announced that Pfizer and Moderna were preferred for use in the country’s booster campaign.
Booster vaccine 3 months after 2nd dose raises antibodies the most: study
The “COV-Boost” study was cited by British officials when they announced that Pfizer and Moderna were preferred for use in the country’s booster campaign.